Merrimack Pharmaceuticals, Inc. (MACK)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
4.87-0.40 (-7.59%)
At close: 4:00 PM EDT

4.95 0.08 (1.64%)
After hours: 5:58 PM EDT

People also watch:
FOLDRLYPACHNHALOSGYP
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open5.26
Prev Close5.27
Bid4.95 x 3000
Ask5.40 x 1000
Day's Range4.82 - 5.39
52wk Range4.82 - 11.00
1y Target EstN/A
Market Cap629.4M
P/E Ratio (ttm)-3.19
Beta2.67
Volume2,617,938
Avg Vol (3m)1,843,648
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • TheStreet.com14 hours ago

    7 Stocks Under $10 Making Big Up Moves

    When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

  • Capital Cube2 days ago

    ETF’s with exposure to Merrimack Pharmaceuticals, Inc. : August 22, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Merrimack Pharmaceuticals, Inc. Here are 5 ETF’s with the largest exposure to MACK-US. Comparing the performance and risk of Merrimack Pharmaceuticals, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Merrimack Pharmaceuticals, Inc. :MACK-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016
    Capital Cube14 days ago

    Merrimack Pharmaceuticals, Inc. :MACK-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016

    Categories: Yahoo Finance Click here to see latest analysis Merrimack Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Merrimack Pharmaceuticals, Inc. – Celgene Corporation, AVEO Pharmaceuticals, Inc., Geron Corporation, Clovis Oncology, Inc. and Cerulean Pharma, Inc. (CELG-US, AVEO-US, GERN-US, CLVS-US and CERU-US) that have ... Read more (Read more...)